CORRELATION OF CIRCULATING EPSTEIN-BARR VIRUS-TARGETED CYTOTOXIC T LYMPHOCYTE PRECURSORS (EBV-CTLp) AND CLINICAL RESPONSE FOLLOWING TABELECLEUCEL (TAB-CEL) INFUSION IN PATIENTS WITH EBV-DRIVEN DISEASE

Hematological Oncology - United Kingdom
doi 10.1002/hon.186_2631